Aminosalicylate drugs for Ulcerative Colitis

9 tracked Aminosalicylate drugs in the Ulcerative Colitis race. The class explanation lives on the Aminosalicylate page; the full indication pipeline across every mechanism is on the Ulcerative Colitis page.

8 approved / phase 41 US approval withdrawn

Head-to-head evidence: Mesalamine (Canasa) vs Mesalamine (Lialda) · mesalamine (Asacol HD) vs Mesalamine (Canasa) · Mesalamine (Lialda) vs Mesalamine (Pentasa) · Mesalamine (Lialda) vs Sulfasalazine · balsalazide disodium (Colazal) vs Mesalamine (Lialda) · mesalamine (Apriso) vs Mesalamine (Lialda)

The roster

← all Aminosalicylate drugs